Intriguing IPOs: ServiceTitan (TTAN) and Anteris Technologies Global (AVR)
The tradespeople SaaS company and the medical device manufacturer have some good qualities, but big warts as well.
Earlier in the year, I really thought the 2024 IPO market was going to be good for investors. Higher-for-longer interest rates, longer holding periods for private equity, and a couple of other factors made me think that 2024 would finally be the year that a slew of higher-quality offerings would be on the table.
That narrative quickly petered out. So much for predictions.
There have been a fair share of companies going public in the second half of the year, but I can’t say many had prospectuses what jumped off the page.
With the year winding down, a couple of companies set to IPO this week appear worthy of a follow up: ServiceTitan (NASDAQ: TTAN) and Anteris Technologies Global (NASDAQ: AVR).
Both of these companies are in my investing blindspots. A software-as-a-service company specializing in productivity application for people in the trades and a medical device startup company. I know that I have likely missed several good opportunities because I didn’t have the reps in these respective industries, so I’m going to step out of my comfort zone a little and peek under the hood at these two IPOs.
Let’s dig in…
Shoutout to Koyfin for their data and charts. Koyfin has become an integral part of how I screen for, track, and analyze companies. It has made the analysis process much faster thanks to having a decade of data at my fingertips instead of manually going through stacks of quarterly and annual filings.
Up your analysis process by Signing up for Koyfin. Click on the link below and receive 10% off your annual subscription.
Disclaimer: I have an affiliate partnership with Koyfin and receive compensation if you sign up via the link above. It helps me fund this endeavor. I would still recommend using it even if I didn’t have this partnership because it’s an awesome product, but I’d be stupid to turn down a revenue opportunity. You get a discount, Koyfin gets new business, and I get a commission. Win-win-win).
Keep reading with a 7-day free trial
Subscribe to Misfit Alpha to keep reading this post and get 7 days of free access to the full post archives.